Free Trade Alerts What is this?
DJI16399.67DOW0.12%
SPX1886.76S&P 5001.29%
NASD4316.0744NASD1.35%

AdviceTrade.com - Where Wall Street Wizards Share Their Trade

Trending Tickers

barron's
Harry Boxer's Charts of the Day

What are
Wall Street's Best & Brightest Buying?

Enter email for
Free Weekly Wizards Newsletter

* In submitting this form you agree to our permission/privacy statement.
Jack Steiman

Jack Steiman - October 20, 2014

Market Continues Counter Trend On Cue... AAPL Earnings This Evening...

I thought that we would move higher off the 10% move lower on the S&P 500, with a retrace to around the gap at 1928, or thereabouts. There, of course, can be no exact number, but my feeling was we'd get to 1928, or so, and, thus far, we're making our way up there nicely, but not easily. It shouldn't be easy, and it's not, but, thus far, it is playing out as expected. Of course, we could go somewhat higher or lower than my target.

Mike Paulenoff

Mike Paulenoff - October 20, 2014

Is IBM's Plight a Micro or a Macro Problem?

In the aftermath of its surprise earnings release before today's open, instead of after tonight's close, International Business Machines Corporation (IBM) is down about 8%, which reflects a huge miss on EPS, on less than expected revenues, and weak forward guidance (the Trifecta!).


Jack Steiman

Jack Steiman - October 17, 2014

Gap Up Off Short Term Bottom...

The stock market never has never been easy. The emotion machine keeps chugging along making sure all of you have a difficult time understanding it. It doesn't want you to ever think it's easy, and it wants to make sure you struggle. Just about everyone does.


Mike Paulenoff

Mike Paulenoff - October 17, 2014

Vicious SPX Rally: Recovery or New Upleg?

The derivatives of the SPX have been climbing since around 7 AM ET Thursday morning, after they retested Wednesday's lows. The cash SPX hit its low at 1820.66 on Wednesday morning, and has climbed to an intraday Friday high (so far) at 1898.16, a gain of 77.50 points (+4.3%).


Harry Boxer

Harry Boxer - October 17, 2014

ACHN, CMRX, NLNK, NVAX

With the market's bounce off the oversold conditions on Thursday, there could be some upside follow-through in the next couple sessions.  Here are four charts to watch, focused on companies in the biotech sector, including a few developing Ebola drugs.


Harry Boxer

Harry Boxer - October 16, 2014

ACHN, CMRX, NLNK, NVAX

The market bounced off of the oversold conditions on Thursday, which is what we expected, but we’re not out of the woods yet. I like this structure. I think it has a lot of promise. The follow-through in the next couple days should be interesting. Friday is Options Expiration Day.